As many as 1,761 new fatalities
India reported 259,170 fresh coronavirus cases on Tuesday, taking the cumulative tally to 15.3 million infections, according to central health ministry data. The country has registered over 200,000 cases for the sixth day in a row. The country saw 1,761 deaths due to the pandemic, taking the death toll to 180,530. This is the highest single-day rise in deaths so far. The active caseload is at 2 million infections, while the total recoveries have surged to 13.1 million. As many as 127 million shots have been administered since the nationwide inoculation programme kicked off on January 16. Of these, 3.2 million were given on Monday. Read more here
Indians are self-prescribing ivermectin, HCQ, dexamethasone
In a growing trend, Indians are now taking Covid drugs—normally given to people in hospitals immediately after testing positive—without a prescription, a report in ThePrint said. These patients turn up at hospitals in later stages and confess to consuming "known Covid drugs” such as hydroxychloroquine (HCQ), ivermectin, doxycycline and dexamethasone to prevent “severe” disease. Read more here
More zero-to-19-year-olds hospitalised in the second wave
The proportion of zero-to-19-year-olds affected in the second wave of Covid-19 has seen a slight increase from the first wave, according to a report in ThePrint that cited an analysis of data for hospitalised patients. Around 5.8 per cent of the patients hospitalised during the second wave of Covid-19 are from this age group, compared to 4.2 per cent in the first wave, from September to November 2020, according to the analysis.
Read more here
EXPLAINED: The ban on US exports of vaccine raw materials
US exports of key raw materials used in the production of some Covid-19 vaccines have been blocked as a result of President Joe Biden’s decision to invoke the US Defense Production Act earlier this year, an explainer in The Indian Express said. While the 1950 Act was originally passed to help ensure supplies during the Korean War, its scope today extends beyond the military to cover natural hazards, terrorist attacks and other national emergencies. Through this law, the US President can order domestic businesses to prioritise federal contracts in such events. Read more here
Regulate remdesivir, but ensure regular supply: Madhya Pradesh HC
Amid a surge in coronavirus cases, the Madhya Pradesh high court has asked the state government to ensure a regular supply of medical oxygen and life-saving drugs such as Remdesivir used in the treatment of Covid-19, a report in the Hindustan Times said. Hearing five petitions that alleged the state government had failed to deal with the spike in cases, the court said, “the state government may regulate the supply of Remdesivir injections and other lifesaving drugs, but the process adopted for this purpose should be hassle-free and should not be cumbersome so as to ensure the supply of the drug in such a way that the time limit from requisition by the treating doctors and supply of medicines does not exceed an hour”. Read more here
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU